Skip to content

Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults

Effect of Homogenization and Pasteurization of Milk on the Stomach Problems in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02219126
Enrollment
11
Registered
2014-08-18
Start date
2014-08-31
Completion date
2018-01-01
Last updated
2018-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unidentified Stomach Discomfort Following Dairy Consumption

Brief summary

This study aims to investigate differences in digestion rates and stomach problems caused by pasteurized and homogenized milk compared with raw milk in healthy adults by ingestible capsule that measures pH and pressure, diary of symptoms, blood glucose and triacylglycerol levels and plasma cytokine levels.

Interventions

OTHERDietary intervention

Sponsors

University of Turku
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Homogenized and pasteurized milk causes stomach problems (self-reported) * unhomogenized and unpasteurized milk does not cause stomach problems (self-reported) * age 18-65 * BMI 18,5 - 30 * hemoglobin under normal range * fasting plasma alanine aminotransferase ALAT \< 60 U/l (normal liver function) * fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function) * fasting plasma creatinine \< 118 umol/l (normal kidney function)

Exclusion criteria

* pace maker * Crohn's disease or other disease of the intestinal tract * intestinal operation within the last 3 months * difficult dysphagia * smoking * constipation

Design outcomes

Primary

MeasureTime frameDescription
Pressure in the intestinal tractDay 0 - Day 5Pressure in the intestinal tract as measured by ingestible Smart Pill -capsule.
Gastrointestinal symptoms (self-reported)Day 0 - Day 5Gastrointestinal symptoms (self-reported) as measured by a questionnaire. The questionnaire is devided into seven types of stomach discomfort, and also includes a possibility to describe a stomach discomfort outside these seven given alternatives. The severity of the symptoms is self-reported on a three-step scale.

Secondary

MeasureTime frame
Plasma triacylglycerols20min, 40min, 60min, 120min, 180min, 240min
Plasma glucose20min, 40min, 60min, 90min, 120min, 180min, 240min
Plasma insulin20min, 40min, 60min, 90min, 120min, 180min, 240min

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026